RT Journal Article
SR Electronic
T1 Mental Health Impact of the First Wave of COVID-19 Pandemic on Spanish Healthcare Workers: a Large Cross-sectional Survey
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.27.20220731
DO 10.1101/2020.10.27.20220731
A1 Alonso, Jordi
A1 Vilagut, Gemma
A1 Mortier, Philippe
A1 Ferrer, Montse
A1 Alayo, Itxaso
A1 Aragón-Peña, Andrés
A1 Aragonès, Enric
A1 Campos, Mireia
A1 del Cura-González, Isabel
A1 Emparanza, José I.
A1 Espuga, Meritxell
A1 Forjaz, M. Joao
A1 Pinto, Ana González
A1 Haro, Josep M.
A1 Fresneña, Nieves López
A1 de Salázar, Alma Martínez
A1 Molina, Juan D.
A1 Lucas, Rafael M. Ortí
A1 Parellada, Mara
A1 Pelayo-Terán, José Maria
A1 Zapata, Aurora Pérez
A1 Pijoan, José I.
A1 Plana, Nieves
A1 Puig, Teresa
A1 Rius, Cristina
A1 Rodriguez-Blazquez, Carmen
A1 Sanz, Ferran
A1 Serra, Consol
A1 Kessler, Ronald C.
A1 Bruffaerts, Ronny
A1 Vieta, Eduard
A1 Pérez-Solá, Víctor
A1 ,
YR 2020
UL http://medrxiv.org/content/early/2020/10/30/2020.10.27.20220731.abstract
AB Introduction Healthcare workers are vulnerable to adverse mental health impacts of COVID-19. We assessed prevalence of mental disorders and associated factors during the first wave of the pandemic among healthcare professionals in Spain.Methods All workers in 18 healthcare institutions (6 AACC) in Spain were invited to a series of online surveys assessing a wide range of individual characteristics, COVID-19 infection status and exposure, and mental health status. Here we report: current mental disorders (Major Depressive Disorder-MDD- [PHQ-8≥10], Generalized Anxiety Disorder-GAD- [GAD-7≥10], Panic attacks, Posttraumatic Stress Disorder –PTSD- [PCL-5≥7]; and Substance Use Disorder –SUD-[CAGE-AID≥2]. Severe disability assessed by the Sheehan Disability Scale was used to identify “disabling” current mental disorders.Results 9,138 healthcare workers participated. Prevalence of screen-positive disorder: 28.1% MDD; 22.5% GAD, 24.0% Panic; 22.2% PTSD; and 6.2% SUD. Overall 45.7% presented any current and 14.5% any disabling current mental disorder. Healthcare workers with prior lifetime mental disorders had almost twice the prevalence of current disorders than those without. Adjusting for all other variables, odds of any disabling mental disorder were: prior lifetime disorders (TUS: OR=5.74; 95%CI 2.53-13.03; Mood: OR=3.23; 95%CI:2.27-4.60; Anxiety: OR=3.03; 95%CI:2.53-3.62); age category 18-29 years (OR=1.36; 95%CI:1.02-1.82), caring “all of the time” for COVID-19 patients (OR=5.19; 95%CI: 3.61-7.46), female gender (OR=1.58; 95%CI: 1.27-1.96) and having being in quarantine or isolated (OR= 1.60; 95CI:1.31-1.95).Conclusions Current mental disorders were very frequent among Spanish healthcare workers during the first wave of COVID-19. As the pandemic enters its second wave, careful monitoring and support is needed for healthcare workers, especially those with previous mental disorders and those caring COVID-19 very often.Competing Interest StatementEV reports personal fees from Abbott, personal fees from Allergan, personal fees from Angelini, grants from Novartis, grants from Ferrer, grants and personal fees from Janssen, personal fees from Lundbeck, personal fees from Sage, personal fees from Sanofi, outside the submitted work. JDM reports personal fees from Janssen, personal fees and non-financial support from Otsuka, personal fees and non-financial support from Lundbeck, personal fees from Angelini, personal fees and non-financial support from Accord, outside the submitted work. In the past 3 years, RCK received support for epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Sage Pharmaceuticals, Shire, Takeda; and served on an advisory board for the Johnson & Johnson Services Ind. Lake Nona Life Project. RCK is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research. All other authors reported no conflict of interest.Funding StatementThis work was supported by Fondo de Investigación Sanitaria, Instituto de Salud Carlos III (Ministerio de Ciencia e Innovación) /FEDER (COV20/00711); ISCIII (Sara Borrell, CD18/00049) (PM); FPU (FPU15/05728) (LB); ISCIII (PFIS, FI18/00012) (BP); Generalitat de Catalunya (2017SGR452).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB Parc de Salut Mar (2020/9203/I)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe de-identified participant data as well as the study protocol and statistical analysis plan used for this study are available upon reasonable request from the corresponding author (JA) as long as the main objective of the data sharing request is replicating the analysis and findings as reported in this paper.